NO984160D0 - Fremgangsmåte for behandling eller forebyggelse av interstitiell cystitt - Google Patents

Fremgangsmåte for behandling eller forebyggelse av interstitiell cystitt

Info

Publication number
NO984160D0
NO984160D0 NO984160A NO984160A NO984160D0 NO 984160 D0 NO984160 D0 NO 984160D0 NO 984160 A NO984160 A NO 984160A NO 984160 A NO984160 A NO 984160A NO 984160 D0 NO984160 D0 NO 984160D0
Authority
NO
Norway
Prior art keywords
interstitial cystitis
treating
preventing interstitial
mammal
preventing
Prior art date
Application number
NO984160A
Other languages
English (en)
Norwegian (no)
Other versions
NO984160L (no
Inventor
Smriti Iyengar
Mark A Muhlhauser
Karl B Thor
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO984160L publication Critical patent/NO984160L/no
Publication of NO984160D0 publication Critical patent/NO984160D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Threshing Machine Elements (AREA)
  • Processing Of Meat And Fish (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nozzles (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heat Treatment Of Articles (AREA)
  • Pistons, Piston Rings, And Cylinders (AREA)
  • Transplanting Machines (AREA)
  • Apparatuses For Bulk Treatment Of Fruits And Vegetables And Apparatuses For Preparing Feeds (AREA)
  • Bidet-Like Cleaning Device And Other Flush Toilet Accessories (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO984160A 1996-03-11 1998-09-10 Fremgangsmåte for behandling eller forebyggelse av interstitiell cystitt NO984160D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1315796P 1996-03-11 1996-03-11
PCT/US1997/003410 WO1997033880A1 (en) 1996-03-11 1997-03-07 Methods of treating or preventing interstitial cystitis

Publications (2)

Publication Number Publication Date
NO984160L NO984160L (no) 1998-09-10
NO984160D0 true NO984160D0 (no) 1998-09-10

Family

ID=21758595

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984160A NO984160D0 (no) 1996-03-11 1998-09-10 Fremgangsmåte for behandling eller forebyggelse av interstitiell cystitt

Country Status (23)

Country Link
EP (1) EP0888330B1 (ko)
JP (1) JP2000506863A (ko)
KR (1) KR19990087671A (ko)
CN (1) CN1217721A (ko)
AT (1) ATE239467T1 (ko)
AU (1) AU730448B2 (ko)
BR (1) BR9708027A (ko)
CA (1) CA2250288A1 (ko)
CZ (1) CZ287798A3 (ko)
DE (1) DE69721747T2 (ko)
DK (1) DK0888330T3 (ko)
EA (1) EA001325B1 (ko)
ES (1) ES2197993T3 (ko)
HU (1) HUP9902884A3 (ko)
IL (1) IL126159A (ko)
NO (1) NO984160D0 (ko)
NZ (1) NZ331811A (ko)
PL (1) PL328959A1 (ko)
PT (1) PT888330E (ko)
RO (1) RO117296B1 (ko)
UA (1) UA62926C2 (ko)
WO (1) WO1997033880A1 (ko)
YU (1) YU39598A (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE449603T1 (de) 1998-09-15 2009-12-15 Lilly Co Eli Verwendung von duloxetine zur behandlung von fibromyalgie
EP1383495A1 (en) * 2001-03-29 2004-01-28 Eli Lilly And Company Duloxetine for treatment of hot flashes
ES2399880T3 (es) * 2002-03-15 2013-04-04 Cypress Bioscience, Inc. Milnaciprán para el tratamiento del síndrome del intestino irritable
DE10247689A1 (de) * 2002-10-12 2004-04-22 Martin Rahe Implantat in der Harnblase
EP1424079A1 (en) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine
EP1904039A2 (en) * 2005-06-20 2008-04-02 Cadila Healthcare Ltd. Controlled release dosage formulation of duloxetine
WO2008077939A2 (en) * 2006-12-27 2008-07-03 Lek Pharmaceuticals D.D. Duloxetine composition
EP2018860A1 (en) * 2007-07-16 2009-01-28 LEK Pharmaceuticals D.D. Duloxetine composition
EP1938840A1 (en) * 2006-12-27 2008-07-02 LEK Pharmaceuticals D.D. Duloxetine composition
WO2009066181A2 (en) * 2007-07-09 2009-05-28 Combino Pharm, S.L. Oral delayed-release duloxentine hydrochloride pellets
RU2719929C1 (ru) * 2018-12-17 2020-04-23 Юрий Анатольевич Игнашов Способ выбора лечения женщин с синдромом болезненного мочевого пузыря

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US574474A (en) * 1897-01-05 Course-indicating apparatus
TW344661B (en) * 1993-11-24 1998-11-11 Lilly Co Eli Pharmaceutical composition for treatment of incontinence

Also Published As

Publication number Publication date
CA2250288A1 (en) 1997-09-18
EP0888330B1 (en) 2003-05-07
IL126159A0 (en) 1999-05-09
ES2197993T3 (es) 2004-01-16
HUP9902884A3 (en) 2000-12-28
DK0888330T3 (da) 2003-09-01
PL328959A1 (en) 1999-03-01
IL126159A (en) 2003-01-12
EA199800816A1 (ru) 1999-02-25
DE69721747T2 (de) 2004-04-01
EP0888330A1 (en) 1999-01-07
EA001325B1 (ru) 2001-02-26
CN1217721A (zh) 1999-05-26
ATE239467T1 (de) 2003-05-15
CZ287798A3 (cs) 1999-05-12
RO117296B1 (ro) 2002-01-30
BR9708027A (pt) 1999-08-03
NO984160L (no) 1998-09-10
EP0888330A4 (en) 1999-04-07
DE69721747D1 (de) 2003-06-12
UA62926C2 (en) 2004-01-15
YU39598A (sh) 1999-09-27
AU2196297A (en) 1997-10-01
KR19990087671A (ko) 1999-12-27
NZ331811A (en) 2001-04-27
WO1997033880A1 (en) 1997-09-18
HUP9902884A2 (en) 2000-07-28
PT888330E (pt) 2003-09-30
JP2000506863A (ja) 2000-06-06
AU730448B2 (en) 2001-03-08

Similar Documents

Publication Publication Date Title
PT971713E (pt) Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
BRPI0006634B8 (pt) composição tópica compreendendo extrato de matricária no tratamento e prevenção de distúrbios inflamatórios
NO984160D0 (no) Fremgangsmåte for behandling eller forebyggelse av interstitiell cystitt
PT1109571E (pt) Metodos de tratamento da hipertensao e composicoes para utilizacao nesses metodos
DE69910425D1 (de) Neue therapeutische verwendung von nicergoline
ATE251462T1 (de) Verfahren zur behandlung von narbengewebe
NO20010390L (no) Behandling av angstsykdommer
EA199800819A1 (ru) Способ лечения биполярного расстройства
LV11593A (lv) Dimetikona pielietojums aizcietejumu arstesana
DK1140119T3 (da) Anvendelse af heparin med lav molekylvægt til forebyggelse og/eller behandling af motorneuronale sygdomme
DK0984787T3 (da) Anvendelse af lavmolekylære hepariner til forebyggelse og behandling af hjerneødemer
DE69635282D1 (de) Behandlung der exzessiven aggressivität mit olanzapine
BR9708037A (pt) Método para o tratamento de abuso de substância
ATE291434T1 (de) Verwendung von angiotensin zur behandlung von krebsmetastasierung
ATE149832T1 (de) Verwendung von cromakalim/brl 38227 zur behandlung der überreaktivität der luftwege
EA199800818A1 (ru) Способ лечения бессонницы
NO985325L (no) Anvendelse av substituert azaspiran ved behandling av astma
UA36485A (uk) Спосіб лікування генералізованого пародонтиту

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application